{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:31:15Z","timestamp":1760243475068,"version":"build-2065373602"},"reference-count":55,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Novel therapies in peripheral arterial disease, such as granulocyte colony-stimulating factor (GCSF) administration, might result in anti-atherosclerotic effects. In this study, we used 10-week-old male ApoE\u2212\/\u2212 mice, which were fed an atherosclerosis-inducing diet for four weeks. At the end of the four weeks, hind limb ischemia was induced through left femoral artery ligation, the atherosclerosis-inducing diet was discontinued, and a normal diet was initiated. Mice were then randomized into a control group (intramuscular 0.4 mL normal saline 0.9% for 7 days) and a group in which GCSF was administrated intramuscularly in the left hind limb for 7 days (100 mg\/kg). In the GCSF group, but not in the control group, we observed significant reductions in the soluble adhesion molecules (vascular cell adhesion molecule-1 (sVCAM-1) and intercellular adhesion molecule-1 (sICAM-1)), sE-Selectin, and plasminogen activator inhibitor (PAI)-1 when they were measured through ELISA on the 1st and the 28th days after hind limb ischemia induction. Therefore, GCSF administration in an atherosclerotic mouse model of hind limb ischemia led to decreases in the biomarkers associated with endothelial activation and thrombosis. These findings warrant further validation in future preclinical studies.<\/jats:p>","DOI":"10.3390\/biomedicines10092303","type":"journal-article","created":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T22:12:43Z","timestamp":1663539163000},"page":"2303","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Granulocyte Colony-Stimulating Factor Ameliorates Endothelial Activation and Thrombotic Diathesis Biomarkers in a Murine Model of Hind Limb Ischemia"],"prefix":"10.3390","volume":"10","author":[{"given":"Angeliki","family":"Valatsou","sequence":"first","affiliation":[{"name":"First Department of Cardiology, \u201cHippokration\u201d General Hospital, University of Athens Medical School, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9260-6306","authenticated-orcid":false,"given":"Panagiotis","family":"Theofilis","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, \u201cHippokration\u201d General Hospital, University of Athens Medical School, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8405-6244","authenticated-orcid":false,"given":"Spyridon","family":"Simantiris","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, \u201cHippokration\u201d General Hospital, University of Athens Medical School, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia","family":"Vogiatzi","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, \u201cHippokration\u201d General Hospital, University of Athens Medical School, 11527 Athens, Greece"},{"name":"Third Department of Cardiology, Thoracic Diseases General Hospital \u201cSotiria\u201d, University of Athens Medical School, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5740-9670","authenticated-orcid":false,"given":"Alexandros","family":"Briasoulis","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3473-1368","authenticated-orcid":false,"given":"Marios","family":"Sagris","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, \u201cHippokration\u201d General Hospital, University of Athens Medical School, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8079-0599","authenticated-orcid":false,"given":"Evangelos","family":"Oikonomou","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, \u201cHippokration\u201d General Hospital, University of Athens Medical School, 11527 Athens, Greece"},{"name":"Third Department of Cardiology, Thoracic Diseases General Hospital \u201cSotiria\u201d, University of Athens Medical School, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexios S.","family":"Antonopoulos","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, \u201cHippokration\u201d General Hospital, University of Athens Medical School, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alkistis","family":"Pantopoulou","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Surgery and Surgical Research \u201cN.S. Christeas\u201d, University of Athens Medical School, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0116-693X","authenticated-orcid":false,"given":"Narjes","family":"Nasiri-Ansari","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Surgery and Surgical Research \u201cN.S. Christeas\u201d, University of Athens Medical School, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Fragopoulou","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Surgery and Surgical Research \u201cN.S. Christeas\u201d, University of Athens Medical School, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Despoina","family":"Perrea","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Surgery and Surgical Research \u201cN.S. Christeas\u201d, University of Athens Medical School, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Tsioufis","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, \u201cHippokration\u201d General Hospital, University of Athens Medical School, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitris","family":"Tousoulis","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, \u201cHippokration\u201d General Hospital, University of Athens Medical School, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCRESAHA.115.307611","article-title":"Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease","volume":"118","author":"Herrington","year":"2016","journal-title":"Circ. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.21037\/atm.2016.06.33","article-title":"Epidemiology of coronary heart disease and acute coronary syndrome","volume":"4","author":"Leischik","year":"2016","journal-title":"Ann. Transl. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1161\/CIR.0000000000001005","article-title":"Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement from the American Heart Association","volume":"144","author":"Criqui","year":"2021","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e1020","DOI":"10.1016\/S2214-109X(19)30255-4","article-title":"Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: An updated systematic review and analysis","volume":"7","author":"Song","year":"2019","journal-title":"Lancet Glob. Health"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/oxfordjournals.eurheartj.a060775","article-title":"The relationship between cigarette smoking and cardiovascular risk factors in peripheral arterial disease compared with ischaemic heart disease. The Edinburgh Artery Study","volume":"16","author":"Leng","year":"1995","journal-title":"Eur. Heart J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1056\/NEJMvcm1406358","article-title":"Clinical Assessment of Peripheral Arterial Disease of the Lower Limbs","volume":"378","author":"Gogalniceanu","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM199202063260605","article-title":"Mortality over a period of 10 years in patients with peripheral arterial disease","volume":"326","author":"Criqui","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","article-title":"2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed by: The European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS)","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_10","first-page":"e726","article-title":"2016 AHA\/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"135","author":"Gornik","year":"2017","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1253\/circj.70.1093","article-title":"Granulocyte colony-stimulating factor: A noninvasive regeneration therapy for treating atherosclerotic peripheral artery disease","volume":"70","author":"Arai","year":"2006","journal-title":"Circ. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.atherosclerosis.2012.07.031","article-title":"Long-term clinical outcome after intramuscular transplantation of granulocyte colony stimulating factor-mobilized CD34 positive cells in patients with critical limb ischemia","volume":"224","author":"Kinoshita","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"105975","DOI":"10.1016\/j.cct.2020.105975","article-title":"Rationale and design of the granulocyte-macrophage colony stimulating factor in peripheral arterial disease (GPAD-3) study","volume":"91","author":"Mehta","year":"2020","journal-title":"Contemp. Clin. Trials"},{"key":"ref_14","first-page":"1523","article-title":"G-CSF and\/or M-CSF accelerate differentiation of bone marrow cells into endothelial progenitor cells in vitro","volume":"15","author":"Zhang","year":"2006","journal-title":"Oncol. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1755-5922.2009.00131.x","article-title":"The role of endothelial progenitor cells in vascular repair after arterial injury and atherosclerotic plaque development","volume":"29","author":"Briasoulis","year":"2011","journal-title":"Cardiovasc. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.exphem.2008.01.011","article-title":"G-CSF treatment after myocardial infarction: Impact on bone marrow-derived vs cardiac progenitor cells","volume":"36","author":"Brunner","year":"2008","journal-title":"Exp. Hematol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jjcc.2012.09.003","article-title":"Early use of granulocyte colony stimulating factor improves survival in a rabbit model of chronic myocardial ischemia","volume":"61","author":"Zhao","year":"2013","journal-title":"J. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1161\/STROKEAHA.110.597799","article-title":"Granulocyte colony-stimulating factor enhances arteriogenesis and ameliorates cerebral damage in a mouse model of ischemic stroke","volume":"42","author":"Sugiyama","year":"2011","journal-title":"Stroke"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1159\/000335869","article-title":"Granulocyte colony-stimulating factor improves cerebrovascular reserve capacity by enhancing collateral growth in the circle of Willis","volume":"33","author":"Duelsner","year":"2012","journal-title":"Cerebrovasc. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.arcmed.2019.07.004","article-title":"Vildagliptin and G-CSF Improved Angiogenesis and Survival after Acute Myocardial Infarction","volume":"50","author":"Li","year":"2019","journal-title":"Arch. Med. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1515\/biol-2020-0078","article-title":"Therapeutic effects of coronary granulocyte colony-stimulating factor on rats with chronic ischemic heart disease","volume":"15","author":"Ren","year":"2020","journal-title":"Open Life Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e13035","DOI":"10.1111\/eci.13035","article-title":"The effect of pegylated granulocyte colony-stimulating factor on collateral function and myocardial ischaemia in chronic coronary artery disease: A randomized controlled trial","volume":"49","author":"Traupe","year":"2019","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1253\/circj.CJ-17-1220","article-title":"Outcome from a Randomized Controlled Clinical Trial- Improvement of Peripheral Arterial Disease by Granulocyte Colony-Stimulating Factor-Mobilized Autologous Peripheral-Blood-Mononuclear Cell Transplantation (IMPACT)","volume":"82","author":"Horie","year":"2018","journal-title":"Circ. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3109\/14653240903518163","article-title":"Safety and efficacy of granulocyte-colony-stimulating factor administration following autologous intramuscular implantation of bone marrow mononuclear cells: A randomized controlled trial in patients with advanced lower limb ischemia","volume":"12","author":"Zafarghandi","year":"2010","journal-title":"Cytotherapy"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1002\/stem.207","article-title":"Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: A phase I\/IIa, multicenter, single-blinded, dose-escalation clinical trial","volume":"27","author":"Kawamoto","year":"2009","journal-title":"Stem Cells"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/sctm.18-0104","article-title":"Autologous Granulocyte Colony-Stimulating Factor-Mobilized Peripheral Blood CD34 Positive Cell Transplantation for Hemodialysis Patients with Critical Limb Ischemia: A Prospective Phase II Clinical Trial","volume":"7","author":"Ohtake","year":"2018","journal-title":"Stem Cells Transl. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/term.3284","article-title":"Filgrastim, fibrinolysis, and neovascularization","volume":"16","author":"Eton","year":"2022","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/FJC.0b013e31820c9776","article-title":"Treatment of leg ischemia with biodegradable gelatin hydrogel microspheres incorporating granulocyte colony-stimulating factor","volume":"57","author":"Kawamura","year":"2011","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1161\/ATVBAHA.120.314595","article-title":"Epidemiology and Risk of Amputation in Patients with Diabetes Mellitus and Peripheral Artery Disease","volume":"40","author":"Barnes","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1253\/circj.72.1385","article-title":"Angiogenesis achieved by granulocyte colony-stimulating factor in combination with bypass surgery in 2 cases of critical limb ischemia","volume":"72","author":"Nakayama","year":"2008","journal-title":"Circ. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/jgm.1298","article-title":"Granulocyte-macrophage colony-stimulating factor gene based therapy for acute limb ischemia in a mouse model","volume":"11","author":"Sacramento","year":"2009","journal-title":"J. Gene Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.2741\/3569","article-title":"Role of peroxynitrite in the redox regulation of cell signal transduction pathways","volume":"14","author":"Liaudet","year":"2009","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.redox.2012.11.003","article-title":"Nitrosative stress and redox-cycling agents synergize to cause mitochondrial dysfunction and cell death in endothelial cells","volume":"1","author":"Diers","year":"2013","journal-title":"Redox Biol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Theofilis, P., Sagris, M., Oikonomou, E., Antonopoulos, A.S., Siasos, G., Tsioufis, C., and Tousoulis, D. (2021). Inflammatory Mechanisms Contributing to Endothelial Dysfunction. Biomedicines, 9.","DOI":"10.3390\/biomedicines9070781"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Theofilis, P., Sagris, M., Antonopoulos, A.S., Oikonomou, E., Tsioufis, C., and Tousoulis, D. (2021). Inflammatory Mediators of Platelet Activation: Focus on Atherosclerosis and COVID-19. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222011170"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.atherosclerosis.2020.07.027","article-title":"A link between inflammation and thrombosis in atherosclerotic cardiovascular diseases: Clinical and therapeutic implications","volume":"309","author":"Oikonomou","year":"2020","journal-title":"Atherosclerosis"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1161\/01.CIR.96.12.4219","article-title":"Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The Atherosclerosis Risk in Communities (ARIC) study","volume":"96","author":"Hwang","year":"1997","journal-title":"Circulation"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1055\/s-0037-1615019","article-title":"Circulating ICAM-1 and VCAM-1 in peripheral artery disease and hypercholesterolaemia: Relationship to the location of atherosclerotic disease, smoking, and in the prediction of adverse events","volume":"79","author":"Blann","year":"1998","journal-title":"Thromb. Haemost."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.6061\/clinics\/2018\/e203","article-title":"Relationship between circulating VCAM-1, ICAM-1, E-selectin and MMP9 and the extent of coronary lesions","volume":"73","author":"Santos","year":"2018","journal-title":"Clinics"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1007\/s00380-018-1315-1","article-title":"Disease-specific characteristics of vascular cell adhesion molecule-1 levels in patients with peripheral artery disease","volume":"34","author":"Edlinger","year":"2019","journal-title":"Heart Vessel."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1161\/ATVBAHA.120.312862","article-title":"Vascular Regeneration in Peripheral Artery Disease","volume":"40","author":"Cooke","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/08977190802090614","article-title":"Treatment with granulocyte colony stimulating factor is associated with improvement in endothelial function","volume":"26","author":"Ikonomidis","year":"2008","journal-title":"Growth Factors"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ahj.2012.12.010","article-title":"Effects of stem cell mobilization by granulocyte colony-stimulating factor on endothelial function after sirolimus-eluting stent implantation: A double-blind, randomized, placebo-controlled clinical trial","volume":"165","author":"Iwata","year":"2013","journal-title":"Am. Heart J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/146532400539198","article-title":"Soluble adhesion molecules (sICAM-1, sL-Selectin, sE-Selectin, sCD44) in healthy allogenic peripheral stem-cell donors primed with recombinant G-CSF","volume":"2","author":"Arslan","year":"2000","journal-title":"Cytotherapy"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/152581602753448612","article-title":"Circulating endothelial adhesion molecules (sE-selectin, sVCAM-1 and sICAM-1) during rHuG-CSF-stimulated stem cell mobilization","volume":"11","author":"Sudhoff","year":"2002","journal-title":"J. Hematother. Stem Cell Res."},{"key":"ref_46","first-page":"578","article-title":"Granulocyte colony-stimulating factor increases expression of adhesion receptors on endothelial cells through activation of p38 MAPK","volume":"89","author":"Fuste","year":"2004","journal-title":"Haematologica"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/1047-2797(92)90092-5","article-title":"On the role of coagulation and fibrinolysis in atherosclerosis","volume":"2","author":"Collen","year":"1992","journal-title":"Ann. Epidemiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1055\/s-0033-1334487","article-title":"Three decades of research on plasminogen activator inhibitor-1: A multifaceted serpin","volume":"39","author":"Declerck","year":"2013","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1111\/j.1538-7836.2005.01420.x","article-title":"PAI-1 and atherothrombosis","volume":"3","author":"Vaughan","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0021-9150(94)05498-8","article-title":"Tissue-plasminogen activator, plasminogen activator inhibitor and risk of peripheral arterial disease","volume":"115","author":"Smith","year":"1995","journal-title":"Atherosclerosis"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejvs.2013.05.011","article-title":"Plasminogen activator inhibitor-1 levels and activity decrease after intervention in patients with critical limb ischaemia","volume":"46","author":"Bjorck","year":"2013","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1161\/ATVBAHA.119.313775","article-title":"Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome","volume":"40","author":"Khoukaz","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_53","first-page":"784128","article-title":"Acute myocardial infarction caused by filgrastim: A case report","volume":"2012","author":"Bilir","year":"2012","journal-title":"Case Rep. Oncol. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1365-2141.1996.d01-1807.x","article-title":"Acute arterial thrombosis due to platelet aggregation in a patient receiving granulocyte colony-stimulating factor","volume":"94","author":"Kawachi","year":"1996","journal-title":"Br. J. Haematol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.thromres.2010.11.004","article-title":"Effects of G-CSF on systemic inflammation, coagulation and platelet activation in patients with acute myocardial infarction","volume":"127","author":"Steppich","year":"2011","journal-title":"Thromb. Res."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/9\/2303\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:32:48Z","timestamp":1760142768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/9\/2303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":55,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["biomedicines10092303"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10092303","relation":{},"ISSN":["2227-9059"],"issn-type":[{"type":"electronic","value":"2227-9059"}],"subject":[],"published":{"date-parts":[[2022,9,16]]}}}